RegenMed, Inc. is raising up to $4.74M on Dealmaker Securities LLC in class b non-voting shares at $12 each; in its filing revenue was $274K and it had 14 employees (Form C/A, 2025-06-16).
RegenMed, Inc. filed a Regulation Crowdfunding offering with the SEC through Dealmaker Securities LLC, with a target of $15K and a maximum of $4.74M. As of November 6, 2026, the offering is withdrawn, on January 29, 2026. The company gives its address as Greenwich, CT (Form C/A, June 16, 2025).
Sell to companies like RegenMed, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · What it is: Reporting ended · C-TR
- · What it is: Offering withdrawn · C-W
- · Intermediary: Dealmaker Securities LLC · Target: $15K · Maximum: $4.74M · Deadline: 2025-12-31 · Security: Class B Non-Voting Shares · C/A
- · Intermediary: Dealmaker Securities LLC · Target: $15K · Maximum: $4.74M · Deadline: 2025-12-31 · Security: Class B Non-Voting Shares · C
- · What it is: Annual report · C-AR
RegenMed, Inc., based in Greenwich, CT, filed 7 Regulation Crowdfunding offering filings with the SEC, the latest on 2025-06-16, raising through Dealmaker Securities LLC. It set a target of $15K and will accept up to $4.74M. The security offered is class b non-voting shares at $12 each. As of its filings the offering is withdrawn on 2026-01-29. 11 filings in this family are on record for the company.
Terms at a glance
| Target | $15K |
| Maximum it will accept | $4.74M |
| Security | Class B Non-Voting Shares |
| Price per unit | $12 |
| Units at the target | 1,208 |
| Raise above the target | accepted, other |
| Deadline | 2025-12-31 |
| Raising through | Dealmaker Securities LLC |
| What the portal is paid, as filed | As compensation for the services provided by DealMaker Securities LLC, the Company is required to pay to DealMaker Securities LLC a cash fee consisting of an eight and one-half percent (8.5%) commission based on the dollar amount of the Securities sold. |
Check before you invest in RegenMed, Inc.: who signed the filing and its own figures, free.
Free to see. No signup.
Want the whole picture on RegenMed, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on RegenMed, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on RegenMed, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
The filing does not state a company valuation or a minimum investment; the offering page on Dealmaker Securities LLC shows those. Check both before you invest.
Money raised before
Earlier raises by this company that are on file, with the amounts as filed. A figure for a raise is what the company reported, not a check of what it received.
| Filed | What | Amount as filed | Filing |
|---|---|---|---|
| 2024-10-01 | Crowdfunding offering (Form C) | $15K to $1.23M | filing |
| 2025-02-18 | Private placement (Form D) | $290K sold | filing |
Offering filings
| Filed | Intermediary | Target | Maximum | Deadline | Security | Filing |
|---|---|---|---|---|---|---|
| 2025-06-16 | Dealmaker Securities LLC | $15K | $4.74M | 2025-12-31 | Class B Non-Voting Shares | C/A |
| 2025-06-13 | Dealmaker Securities LLC | $15K | $4.74M | 2025-12-31 | Class B Non-Voting Shares | C |
| 2025-02-07 | StartEngine Primary, LLC | $15K | $1.23M | 2025-03-06 | Class B Non-Voting Common Stock | C/A |
| 2025-01-28 | StartEngine Primary, LLC | $15K | $1.23M | 2025-04-30 | Class B Non-Voting Common Stock | C/A |
| 2024-12-18 | StartEngine Primary, LLC | $15K | $1.23M | 2025-03-03 | Class B Non-Voting Common Stock | C/A |
| 2024-10-02 | StartEngine Primary, LLC | $15K | $1.23M | 2024-12-30 | Class B Non-Voting Common Stock | C/A |
| 2024-10-01 | StartEngine Primary, LLC | $15K | $1.23M | 2024-12-30 | Class B Non-Voting Common Stock | C |
Financials the company filed
Figures from the C/A filed 2025-06-16, as the company reported them.
| As filed | Most recent fiscal year | Prior fiscal year |
|---|---|---|
| Revenue | $274K | $78K |
| Net income | -$1.81M | -$1.55M |
| Total assets | $506K | $603K |
| Cash and equivalents | $41K | |
| Short-term debt | $0 | |
| Long-term debt | $0 |
Employees at filing: 14.
Revenue went from $78K to $274K (+250%). Net loss was $1.81M, against a loss of $1.55M the year before. It reported $41K in cash and $0 in debt. These are the company's own figures from the Form C/A filed 2025-06-16.
Progress updates
2025-03-11, C-U:
At the close of the offering, the Issuer closed on $258,487.08 and 32,749 shares.
People who signed the filing
- Michael Tierney, Chief Executive Officer, Director
- Susan E. Ryder, Director, CFO
- Laura Prey, Director
Records matched to this company: a withdrawn offering. Details and links are in the check at the top of the page.
Every filing
| Filed | What it is | Filing |
|---|---|---|
| 2026-03-09 | Reporting ended | C-TR |
| 2026-01-29 | Offering withdrawn | C-W |
| 2025-06-16 | Offering amended | C/A |
| 2025-06-13 | Offering | C |
| 2025-04-30 | Annual report | C-AR |
| 2025-03-11 | Progress update | C-U |
| 2025-02-07 | Offering amended | C/A |
| 2025-01-28 | Offering amended | C/A |
| 2024-12-18 | Offering amended | C/A |
| 2024-10-02 | Offering amended | C/A |
| 2024-10-01 | Offering | C |
What to check before investing
- Read the offering page on Dealmaker Securities LLC: it states the valuation or cap and the minimum investment, which the SEC filing does not.
- Compare the terms above with the numbers: what does the price imply against revenue of $274K?
- Look at who signed the filing and what else they have run (the founder Snapshot below).
- Check the deadline and what happens if the target is missed.
- You cannot easily sell a crowdfunding security; invest only what you can leave tied up.
A crowdfunding round is won in public. FoxPlug turns your commits, deploys and releases into the posts and visuals that keep the story moving while the offering is open.
Build your launch kitRun a Snapshot on Michael Tierney: other companies, roles and the record behind them. Order Full Report from there if you need more.
Snapshot the foundersTools for this story
Each opens in a new tab, filled in for RegenMed, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company raising money from the public under Regulation Crowdfunding has to file with the SEC before the offering opens, and has to raise through a single registered intermediary: a funding portal or a broker-dealer. The first filing, Form C, states how much the company is trying to raise, the most it will accept, the deadline, the security and its price, the intermediary and what the intermediary is paid, and two years of the company's own financial figures.
After that the company files amendments when terms change, progress updates as the raise moves, and an annual report each year until it stops reporting. Every row here is one of those filings, linked to the filing itself, so each figure can be checked at the source. Figures are exactly as the company filed them; where a filing leaves a field blank, so does this page. Nothing here is investment advice, and a filing is the company's own statement, not a verification of it.